One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention

Background: Bivalirudin reduces ischemic and hemorrhagic events in patients undergoing primary percutaneous coronary intervention (PCI), but the safety and efficacy for such individuals are unclear. Our aim was to evaluate the long-term safety and efficacy of bivalirudin in patients undergoing elect...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Jiawen Li, Yulong Li, Shuhong Su, Zhifang Wang, Haiwei Liu, Weixian Yang, Shubin Qiao, Yuejin Yang, Bo Xu, Runlin Gao, Jinqing Yuan, Xueyan Zhao
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	IMR Press 2023-07-01
סדרה:	Reviews in Cardiovascular Medicine
נושאים:	bivalirudin elective percutaneous coronary intervention glycoprotein iib/iiia inhibitors unfractionated heparin
גישה מקוונת:	https://www.imrpress.com/journal/RCM/24/8/10.31083/j.rcm2408218
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!